(NYSE: ALB) Albemarle's forecast annual revenue growth rate of 6.81% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 3.26%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.07%.
Albemarle's revenue in 2025 is $5,093,671,000.On average, 9 Wall Street analysts forecast ALB's revenue for 2025 to be $589,125,960,841, with the lowest ALB revenue forecast at $555,947,818,650, and the highest ALB revenue forecast at $610,307,160,918. On average, 9 Wall Street analysts forecast ALB's revenue for 2026 to be $650,641,439,898, with the lowest ALB revenue forecast at $617,955,120,328, and the highest ALB revenue forecast at $711,260,225,130.
In 2027, ALB is forecast to generate $738,415,658,116 in revenue, with the lowest revenue forecast at $682,748,632,450 and the highest revenue forecast at $835,274,828,486.